Ledger.Open graph →

SEC Form D · filed August 18, 2022

Cerecin Inc

Offering

$40.0M

Sold

$7.2M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

DENVER, CO

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Nicholas C. Stacey · Denver, COExec · Director Claude T. Nash · Denver, CODirector Kikab T. Kim · Denver, CODirector Wolfgang T. Reichenberger · Denver, CODirector Hans-Jurgen S. Woerle · Denver, CODirector Samuel T. Henderson · Denver, COExec Gurpreet S. Vohra · Denver, CODirector Jerris T. Knaisch · Denver, COExec Adam Guggenheim · Palos Verdes Estates, CADirector Boaz Gorfung · Kadima, L3Exec Walker Moody · Houston, TXDirector Scott M. Verlander · Jacksonville, FLExec · Director Doron Cohen · Kadima, L3Director Yossi Shemesh · Kadima, L3Director Daniel Pickering · Houston, TXDirector Oluwaseun Oyinsan · Millbury, MAExec Milan S. Vinnola · Denver, COExec Nayel M. Nassar · Denver, CODirector Aurora R. Cassirer · Elmsford, NYDirector Maria R. Schroeder · Elmsford, NYExec Peter Kim · Irvine, CAExec Pranay Parikh · Irvine, CADirector Jeffrey Harris · Boca Raton, FLDirector Rishabh Agarwal · New Haven, CTDirector Michael Schumacher · Carlsbad, CAExec · Director Milan S. Vinnola · Denver, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗